Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colorectal Neoplasms 56Carcinoma, Non-Small-Cell Lung 35Breast Neoplasms 29Neoplasm Metastasis 23Glioblastoma 23Colonic Neoplasms 23Rectal Neoplasms 19Ovarian Neoplasms 16Neoplasms 15Brain Neoplasms 12Lung Neoplasms 11Pancreatic Neoplasms 10Glioma 10Fallopian Tube Neoplasms 10Carcinoma, Renal Cell 10Carcinoma, Hepatocellular 9Gliosarcoma 7Adenocarcinoma of Lung 7Kidney Neoplasms 6Liver Neoplasms 5Astrocytoma 5Sarcoma 4Recurrence 4Oligodendroglioma 4Melanoma 4Uterine Cervical Neoplasms 3Lymphoma, Non-Hodgkin 3Leukemia, Myeloid, Acute 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2

Interventions

Pemetrexed 3Carboplatin 3osimertinib 2patritumab 1napabucasin 1atezolizumab 1alectinib 1Technetium Tc 99m Aggregated Albumin 1Patient Reported Outcome Measures 1Paclitaxel 1Erlotinib Hydrochloride 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Bronchial Neoplasms × Bevacizumab × Clear all
NCT04512430 2025-04-02

Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients

Fundación GECP

Phase 2 Terminated
4 enrolled 9 charts
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Respiratory Tract Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡